GPT and metabolic dysfunction-associated steatotic liver disease: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are widely used in general clinical practice to measure liver injury and have been proved to be associated with metabolic diseases, cardiovascular diseases (12), non-alcoholic fatty liver disease (NAFLD) (13), and upper tract urothelial cancer (14).